These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1452 related items for PubMed ID: 18774180

  • 1. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M.
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR, BOLDER II Study Group.
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [Abstract] [Full Text] [Related]

  • 3. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, BOLDER Study Group.
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [Abstract] [Full Text] [Related]

  • 4. Quetiapine for the treatment of bipolar II depression: analysis of data from two randomized, double-blind, placebo-controlled studies.
    Suppes T, Hirschfeld RM, Vieta E, Raines S, Paulsson B.
    World J Biol Psychiatry; 2008 Jun; 9(3):198-211. PubMed ID: 17853277
    [Abstract] [Full Text] [Related]

  • 5. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies.
    Vieta E, Mullen J, Brecher M, Paulsson B, Jones M.
    Curr Med Res Opin; 2005 Jun; 21(6):923-34. PubMed ID: 15969892
    [Abstract] [Full Text] [Related]

  • 6. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH, EMBOLDEN II (Trial D1447C00134) Investigators.
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [Abstract] [Full Text] [Related]

  • 7. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Feb; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I (Trial 001) Investigators.
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [Abstract] [Full Text] [Related]

  • 9. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D.
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [Abstract] [Full Text] [Related]

  • 10. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 11. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Aug; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 12. Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.
    McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE.
    J Affect Disord; 2010 Jul; 124(1-2):157-63. PubMed ID: 19963274
    [Abstract] [Full Text] [Related]

  • 13. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.
    Calabrese JR, Keck PE, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J.
    Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719
    [Abstract] [Full Text] [Related]

  • 14. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA, Jones M, Paulsson B.
    J Affect Disord; 2007 Jul; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF.
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of quetiapine in bipolar depression.
    Bogart GT, Chavez B.
    Ann Pharmacother; 2009 Nov; 43(11):1848-56. PubMed ID: 19809011
    [Abstract] [Full Text] [Related]

  • 17. Assessing health-related quality of life in generalized anxiety disorder using the Quality Of Life Enjoyment and Satisfaction Questionnaire.
    Wyrwich K, Harnam N, Revicki DA, Locklear JC, Svedsäter H, Endicott J.
    Int Clin Psychopharmacol; 2009 Nov; 24(6):289-95. PubMed ID: 19707153
    [Abstract] [Full Text] [Related]

  • 18. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study.
    Cookson J, Keck PE, Ketter TA, Macfadden W.
    Int Clin Psychopharmacol; 2007 Mar; 22(2):93-100. PubMed ID: 17293709
    [Abstract] [Full Text] [Related]

  • 19. Bipolar depression: a new role for atypical antipsychotics?
    Keck PE.
    Bipolar Disord; 2005 Mar; 7 Suppl 4():34-40. PubMed ID: 15948765
    [Abstract] [Full Text] [Related]

  • 20. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E, Goldberg JF, Mullen J, Vågerö M, Paulsson B.
    J Affect Disord; 2007 Mar; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.